Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

87.17
-2.7700-3.08%
Post-market: 87.450.2800+0.32%19:55 EDT
Volume:1.34M
Turnover:117.16M
Market Cap:3.03B
PE:-19.23
High:90.91
Open:90.19
Low:85.71
Close:89.94
52wk High:95.95
52wk Low:30.82
Shares:34.77M
Float Shares:28.68M
Volume Ratio:1.79
T/O Rate:4.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5319
EPS(LYR):-3.9613
ROE:-26.36%
ROA:-17.95%
PB:4.93
PE(LYR):-22.01

Loading ...

Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
1 hour ago

Disc Medicine Inc - Shares Sold at $84.00

THOMSON REUTERS
·
1 hour ago

Disc Medicine Updates Hematology Portfolio and Strategic Priorities

TIPRANKS
·
10 hours ago

Disc Medicine Provides Update on Cash Position, Hematology Portfolio

MT Newswires Live
·
Yesterday

Disc Medicine Launches $220 Million Stock and Pre-Funded Warrant Offering

Reuters
·
Yesterday

Disc Medicine Inc - Proceeds to Support Commercialization of Bitopertin for Epp and Xlp

THOMSON REUTERS
·
Yesterday

Disc Medicine Inc - Announces $220 Mln Underwritten Offering of Common Stock

THOMSON REUTERS
·
Yesterday

BRIEF-Disc Medicine Provides Update On Hematology Portfolio

Reuters
·
Yesterday

Disc Medicine Secures FDA Priority Review Voucher for Bitopertin NDA in EPP

Reuters
·
Yesterday

Disc Medicine Inc: Accelerating Efforts for Potential Earlier Approval and Commercialization of Bitopertin for Epp in US

THOMSON REUTERS
·
Yesterday

Disc Medicine Inc - Initial Data From Phase 2 Study in Anemia of Mf by Year End, Topline Data Expected in 2026

THOMSON REUTERS
·
Yesterday

Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones

THOMSON REUTERS
·
Yesterday

Disc Medicine Director Cashes In on Major Stock Sale!

TIPRANKS
·
Oct 18

Disc Medicine Inc. Director Kevin Bitterman Reports Disposal of Common Shares

Reuters
·
Oct 18

Disc Medicine's Bitopertin Could See US FDA Approval by Early February 2026, Wedbush Says

MT Newswires Live
·
Oct 18

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday

Benzinga_recent_news
·
Oct 18

Leerink Partners Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
Oct 17

Disc Medicine Up Nearly 23%, On Pace For Largest Percent Increase Since November 2024 -- Data Talk

Dow Jones
·
Oct 17

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

Benzinga_recent_news
·
Oct 17

Disc Medicine rises 25.5%

TIPRANKS
·
Oct 17